Land: Südafrika
Sprache: Englisch
Quelle: South African Health Products Regulatory Authority (SAHPRA)
Smith_kb
POLIO SABIN™ (oral) POLIO SABIN™ (oral) QUALITATIVE COMPOSITION: POLIO SABIN ™ (oral) vaccine is a stabilised preparation of the live attenuated poliomyelitis virus of the Sabin strain type 1 (LS-c, 2ab). The virus is propagated in primary monkey kidney tissue culture. POLIO SABIN ™ (oral) meets the World Health Organisation requirements for biological substances and for poliomyelitis vaccine (oral). CLINICAL PARTICULARS: Therapeutic indications: POLIO SABIN ™ (oral) is indicated for active immunisation of infants and susceptible children and adults against infection caused by poliovirus of type 1. Posology and method of administration: Posology: In a multidose container one immunising dose is contained in two drops. The drops are delivered from the special dropper supplied with the multidose glass vials. As vaccination schemes vary from country to country, the advised schedule for each country must be in accordance with the national recommendations. Infants: The primary immunisation course is three doses of POLIO SABIN ™ (oral) vaccine. They should be administered with an interval of at least one month. POLIO SABIN ™ (oral) may be given at birth provided it is realised that the take rate is likely to be lower, and that three additional doses are required later in life to give adequate protection. Children and adults: In order to maintain the level of protection against polio virus infection, it is recommended to give a booster dose at the time of school entry and again on leaving school and occasionally in adult life when a person is likely to be exposed to a high risk of infection, as when travelling to endemic areas. Method of administration: POLIO SABIN ™ (oral) is for oral use only. The vaccine may be administered directly or mixed with be Lesen Sie das vollständige Dokument